Last month, along with 16,000 diabetes researchers and healthcare professionals, I got the chance to attend the American Diabetes Association meeting in Orlando. Here’s what was on the agenda for Type 2 research. DiRECT gets air time With the first-year results of the DiRECT trial announced in December last year, the second-year results are hotly anticipated. In the meantime,…

Genetics was high on the agenda at this year’s EASD, with a move toward challenging the ‘one-size-fits-all’ approach of diagnosing and treating different types of diabetes. Using genetics to prevent Type 1 TrialNet screens relatives of people with Type 1 diabetes to work out their personal risk of developing the condition. They have now screened…

Last week I found out about a new diabetes research study from Denmark, which found that moderate drinking was associated with a lower risk of Type 2 diabetes than not drinking at all. Well, of course the papers loved it. Especially as it went live on a Friday. Millions of people across the UK finishing a…